Diabetic eye disease is occurring in younger populations, which means it's time to rethink anti-VEGF standards.
You know the type. When their team is doing well, sports fans are upbeat.
I have long been an advocate of giving patients the best possible uncorrected distance vision with toric IOLs.
Editor’s Note: Welcome to “Eye Catching: Let's Chat,” a blog series featuring contributions from members of the ophthalmic community.
Hyaluronic acid (HA) hydrogels have long been recognized for their dermal and ocular wound-healing properties, ability to support stem-cell regenerative medicines, joint lubrication and cushioning, and ocular hydrating capabilities.1
In the first part of his Clinical Innovation series, Josh Mali, MD, shares how this novel home-use device is the new standard of care for AMD monitoring. Future blogs in the series will discuss the increased efficacy of patient monitoring and present case examples.